AngioDynamics (NSDQ:ANGO) announced that it received FDA 510(k) clearance and CE Mark approval for its SmartPort+ implantable port product.
SmartPort+ is an implantable, subcutaneous port for those who require long-term access to the central venous system for blood specimen withdrawal and administration of fluids, according to a news release.